right.. but a chore & $$ to haul them into court quickly to litigate the clause.. Braeburn can transfer itself & assets to anyone for a $1 (they are private).. possible obstacle may be clauses in new funding .. but who knows the terms.. "$110 million mezzanine round of financing led by Wellington Capital Management. Other new investors participating in the financing include Avista Capital Partners, RA Capital Management, New Leaf Venture Partners, Deerfield Management, and Rock Springs Capital".. $ were targeted specifically for dev & marketing cam2038 https://www.prnewswire.com/news-releases/braeburn-announces-completion-of-110-million-financing-300581077.html .. besides probuphine all Braeburn is advertising on their web site is cam2038..
I believe they were tasked also to complete some post approval clin trials on probuphine & advance prubuphine for pain.. but haven't seen any of that either..
also wondering what Braeburn owes Camurus AB for the rights to CAM2038 .. CAMX is moving right along in EU to get Cam2038 approved..https://www.bloomberg.com/quote/CAMX:SS...